Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The galactose-3-O-sulfotransferase 4 pseudogene (ENSG00000274977) is a non-functional DNA sequence homologous to the GAL3ST4 gene, which encodes an enzyme that catalyzes the transfer of sulfate to galactose residues in O-linked glycoproteins[2]. Unlike the functional GAL3ST4 gene, the pseudogene does not produce an active enzyme and does not participate in known biological processes or disease mechanisms[2]. Key distinctions: - The functional GAL3ST4 gene encodes an enzyme involved in glycoprotein sulfonation, is classified as an enzyme, and has limited disease associations[1][4][7][10]. - The GAL3ST4 pseudogene (ENSG00000274977) is not a functional target, not therapeutic, and does not fulfill typical drug target criteria[2]. Summary: This entry should not be used as a canonical therapeutic target as it refers to a pseudogene, not to the active galactose-3-O-sulfotransferase 4 enzyme[2]. If seeking information for functional therapeutic targeting, refer to GAL3ST4 rather than its pseudogene.
None (no mechanism as pseudogene does not produce a protein target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on galactose-3-O-sulfotransferase 4 pseudogene (No widely used abbreviation for the pseudogene; GAL3ST4 is for the functional gene[2]).